Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
794.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 4.00 (0.505%)
Market Cap: £366.00m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Director/PDMR Shareholding

28 Jun 2019 11:30

RNS Number : 8425D
Porvair PLC
28 June 2019
 

 

Porvair plc ("Porvair" or the "Company")

Director's Shareholding

The Company was notified on 27 June 2019 of the following exercises of Long Term Share Plan Share options ("LTSP") over ordinary shares of 2 pence each in the Company ("Ordinary Shares").

Director

Scheme

Year of grant

Exercise price

Options exercised

Ben Stocks

LTSP

2016

2.0p

96,700

Chris Tyler

LTSP

2016

2.0p

67,900

On the same day, the Company was notified that Ben Stocks, Group CEO, and Chris Tyler, Group Finance Director, had sold the following Ordinary Shares in order to meet the cost of exercise, the personal taxation liabilities arising on the options and certain other financial commitments.

Director

Transaction

Price

Number

Ben Stocks

Sale

£5.82

76,700

Chris Tyler

Sale

£5.82

52,900

The Company was also notified on 27 June 2019 of the following purchase on 7 June 2019 by Ben Stocks of Ordinary Shares pursuant to the Group's dividend reinvestment plan ("DRIP").

Director

Transaction

Price

Number

Ben Stocks

DRIP purchase

£5.68

3,513

Following these dealings, Ben Stocks' holding in the Company has increased by 23,513 Ordinary Shares to 762,933 Ordinary Shares, representing approximately 1.7 per cent. of the Company's issued share capital. Chris Tyler's holding in the Company has increased by 15,000 Ordinary Shares to 494,311 Ordinary Shares, representing approximately 1.1 per cent. of the Company's issued share capital.

As at today's date, the total number of voting rights in the Company is 45,843,599. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information, please contact:

Porvair plc

01553 765 500

Chris Tyler, Group Finance Director

Notes to Editors

Porvair is a group of specialist filtration and environmental technology businesses. Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. It operates in three divisions: Aerospace & Industrial; Laboratory; and Metal Melt Quality.

 

The information below (set out in accordance with the requirements of EU Market Abuse Regulation) provides further detail:

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Christopher Tyler

2.

Reason for the notification

a.

Position/status

CFO

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Porvair plc

b.

LEI

213800ECKHS8LAQO3C45

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type

of instrument

Identification code

Ordinary shares of 2p

 

 

GB0006963689

b.

Nature of the transaction

 

1) Exercise of LTSP share options

 

2) Sale of ordinary shares

 

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

1)

£0.02

67,900

2)

£5.82

52,900

d.

Aggregated information

· Aggregated volume

· Price

 

 

As above

e.

Date of the transaction

27 June 2019

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Ben Stocks

2.

Reason for the notification

a.

Position/status

CEO

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Porvair plc

b.

LEI

213800ECKHS8LAQO3C45

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type

of instrument

Identification code

Ordinary shares of 2p

 

 

GB0006963689

b.

Nature of the transaction

 

1) Exercise of LTSP share options

 

2) Sale of ordinary shares

 

3) Purchase of shares through the dividend reinvestment plan

 

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

1)

£0.02

96,700

2)

£5.82

76,700

3)

£5.68

3,513

d.

Aggregated information

· Aggregated volume

· Price

 

 

As above

e.

Date of the transaction

27 June 2019

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHZMGZVGRKGLZM
Date   Source Headline
9th Dec 20217:00 amRNSPre-close trading update and Notice of Results
23rd Nov 202112:30 pmRNSHolding(s) in Company
5th Nov 20214:40 pmRNSSecond Price Monitoring Extn
5th Nov 20214:35 pmRNSPrice Monitoring Extension
8th Oct 20214:40 pmRNSSecond Price Monitoring Extn
8th Oct 20214:35 pmRNSPrice Monitoring Extension
27th Sep 20214:41 pmRNSSecond Price Monitoring Extn
27th Sep 20214:35 pmRNSPrice Monitoring Extension
16th Sep 20213:31 pmRNSDirector/PDMR Shareholding
14th Sep 20217:00 amRNSNine Month Trading Update
11th Aug 20214:41 pmRNSSecond Price Monitoring Extn
11th Aug 20214:35 pmRNSPrice Monitoring Extension
10th Aug 20214:40 pmRNSSecond Price Monitoring Extn
10th Aug 20214:35 pmRNSPrice Monitoring Extension
4th Aug 20217:00 amRNSBlock listing Interim Review
5th Jul 20217:00 amRNSHalf Year Results 2021
30th Jun 20217:00 amRNSTotal Voting Rights
29th Jun 20214:41 pmRNSSecond Price Monitoring Extn
29th Jun 20214:36 pmRNSPrice Monitoring Extension
23rd Jun 20214:41 pmRNSSecond Price Monitoring Extn
23rd Jun 20214:35 pmRNSPrice Monitoring Extension
10th May 20214:40 pmRNSSecond Price Monitoring Extn
10th May 20214:36 pmRNSPrice Monitoring Extension
21st Apr 20212:40 pmRNSGrant of LTSP awards
20th Apr 202112:30 pmRNSAGM resolutions and Board changes
20th Apr 20217:00 amRNSAGM Trading Update
1st Apr 20214:28 pmRNSTotal Voting Rights
17th Mar 20214:57 pmRNSHolding(s) in Company
16th Mar 20212:01 pmRNSHolding(s) in Company
2nd Mar 20214:40 pmRNSSecond Price Monitoring Extn
2nd Mar 20214:35 pmRNSPrice Monitoring Extension
1st Mar 20213:27 pmRNSTotal Voting Rights
26th Feb 20217:00 amRNSAcquisition of Kbiosystems Limited
22nd Feb 20213:00 pmRNSHolding(s) in Company
19th Feb 20214:35 pmRNSPrice Monitoring Extension
10th Feb 20214:36 pmRNSPrice Monitoring Extension
8th Feb 20217:00 amRNSBlock listing Interim Review
8th Feb 20217:00 amRNSTotal Voting Rights
3rd Feb 20214:41 pmRNSSecond Price Monitoring Extn
3rd Feb 20214:36 pmRNSPrice Monitoring Extension
3rd Feb 20219:42 amRNSHolding(s) in Company
2nd Feb 20217:00 amRNSGrant of LTSP awards
1st Feb 20217:00 amRNSFinal Results
6th Jan 20214:41 pmRNSSecond Price Monitoring Extn
6th Jan 20214:35 pmRNSPrice Monitoring Extension
30th Dec 20203:30 pmRNSHolding(s) in Company
30th Dec 20203:30 pmRNSHolding(s) in Company
9th Dec 20203:47 pmRNSHolding(s) in Company
8th Dec 20207:00 amRNSPre-close trading update
23rd Nov 20204:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.